SUPERFASLIGAND (soluble) (human), (recombinant) features an N-terminus linker shown to improve stability and enhance immune activation compared to recombinant ligands alone. SUPERFASLIGAND (soluble) (human), (recombinant) features an N-terminus linker shown to improve stability and enhance immune activation compared to recombinant ligands alone. Alternative name: FasL (oligomer), APO-1L (oligomer), CD95L (oligomer), CD178 (oligomer), TNFSF 6 (oligomer). Concentration: 0.1mg/ml after reconstitution. Purity: ≥95% (SDS-PAGE). Formulation: Lyophilized. Contains PBS. Source: Produced in HEK 293 cells. The extracellular domain of human FasL (APO-1L; CD95L; CD178) (aa 103-281) is fused at the N-terminus to a linker peptide (26 aa) and a FLAG-tag. Glycosylation of rhs SUPERFASLIGAND is similar to natural human FasL. Specificity: Binds to human, mouse and rat Fas (CD95; APO-1). Long Term Storage: -20°C. Applications: ELISA .